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based on mutations found in cancer†
M. Matovina, a D. Agic´, b M. Abramic´,a S. Matic´,a Z. Karacˇic´a and S. Tomic´ *a
Dipeptidyl peptidase III (DPP III) is a cytosolic enzyme belonging to the metallopeptidase family M49, involved
in the ﬁnal steps of protein catabolism. More than a hundred missense mutations can be found in the coding
region of the human DPP3 gene when searching cBioPortal for Cancer Genomics. The role of two highly
conserved residues in the family M49, whose mutations G313W and R510W were detected in human
cancer, was investigated using combined experimental and computational approaches (substrate docking
and MD simulations). Several mutants of human DPP III were expressed and puriﬁed as recombinant
proteins, and their biochemical properties were determined. The conservative substitution of Arg510 with
lysine mildly decreased enzyme activity activity for Arg-Arg-2-naphtylamide substrate, while the
substitutions of Arg510 with glutamine and Gly313 with alanine substantially decreased enzyme activity, and
tryptophan substitutions found in cancer, G313W and R510W, almost abolished enzyme activity. MD
simulations showed that substitution of Gly313, and especially Arg510 with tryptophan, signiﬁcantly
increases the enzyme ﬂexibility, particularly that of the binding site including the H450ELLGH455 motif, and
inﬂuences the substrate interactions with the catalytic His568. The results clearly indicate that, besides the
enzyme structure, its dynamics properties also signiﬁcantly inﬂuence the human DPP III activity.Introduction
The dipeptidyl-peptidase III (DPP III; EC 3.4.14.4) is a monozinc
exopeptidase from the metallopeptidase family M49 (according
to the MEROPS database, http://www.merops.ac.uk), found to
be broadly distributed in mammalian tissues, and thought to
contribute to the nal steps of normal intracellular protein
catabolism. There are strong indications of its role in the
endogenous pain-modulation system,1 as well as in the endog-
enous defence against oxidative stress.2 Pathophysiological
roles of human DPP III (h.DPP III) are indicated in malignant
growth,3,4 and inuenza virus infection.5 Recently, it was proven
that DPP III contributes to the activation of transcription factor
Nrf2, a constituent of the Nrf2-Keap1 signalling pathway, the
main defence mechanism against many environmentally toxic
agents and carcinogens in cells.6,7 However, (patho)physiolog-
ical roles of DPP III are still not elucidated, and better under-
standing of its broad substrate specicity would be a step
toward understanding its biological function.
From a structural point of view, the DPP III is a two-domain
protein with the motifs HEXXGH and EE*XR(K)AE(D) consid-
ered as its trademark.8,9 Histidines from the rst motif andistry, Ruder Bosˇkovi´c Institute, Bijenicˇka
ic@irb.hr
sijek, Faculty of Agriculture in Osijek,
tion (ESI) available. See DOI:
4glutamate* from the second one take part in the zinc ion
coordination, while the glutamate from the rst motif is crucial
for the catalytic activity of DPP III, namely the hydrolysis of
dipeptides from the N-terminus of its substrates consisting of
three or more amino acids.10
Until now several 3D structures of h.DPP III have been
determined, ligand free and in complex with natural peptides.
The structure of the ligand-free enzyme (PDB codes: 3FVY and
5EGY) was determined in the so-called open and closed form,
while that of the liganded enzyme only in a more compact,
closed, form (PDB codes: 3T6B, 3T6J, 5E33, 5E3A, 5E2Q, 5EHH,
5E3C).11 The open, ligand-free enzyme structure is characterized
with the wide inter-domain cle (40 A˚ wide and 40 A˚ high)
with the catalytic zinc ion bound at its “roof”. Using computa-
tional approaches we have traced the protein closure,12,13 gained
better insight into enzyme broad substrate specicity and
determined the reaction mechanism of h.DPP III.14–16
More than hundred missense mutations can be found in the
coding region of h.DPP III gene by searching cBioPortal for
Cancer Genomics (http://www.cbioportal.org/; accessed
September 2014).17,18 Most of those mutations were predicted to
have low or medium impact on protein function, however, two
of them, G313W and R510W, which reside in the conserved
regions 1 and 4 of DPP III,9 were predicted to have high inu-
ence on protein functionality. Those mutations were found in
the tumour samples from lung adenocarcinoma, and colorectal
adenocarcinoma samples, respectively. Mutation G313W was
found in the provisional TCGA (The Cancer Genome Atlas)This journal is © The Royal Society of Chemistry 2017
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View Article Onlinestudy, and was removed from newer releases of cBioPortal
(http://www.cbioportal.org/; accessed October 2015), however,
this study was aimed at nding the cause of the DPP III inac-
tivation by this mutation, and not at studying the potential role
of these mutations in the development of cancer so we decided
to proceed with the research of this mutant regardless of that.
We investigated the inuence of those mutations on the enzyme
biochemical and physicochemical properties. Those mutants
exhibited almost complete loss of activity towards synthetic
substrate, Arg-Arg-2-naphthylamide (Arg2-2NA; RRNA)
compared to the wild type (wt) h.DPP III, and we set out to
determine the cause of this activity loss by combining experi-
mental approaches with computational simulations. In order to
determine the root of the activity loss in these two mutants, we
investigated three other amino acid substitutions, in which the
native amino acid residues were substituted by an amino acid
that diﬀers less from the original than mutants found in
tumour cells. In this way we were able to gain better under-
standing of how amino acid substitutions at particular position
inuence enzyme structure and activity. Altogether, we analysed
5 diﬀerent mutants, G313W and R510W that were found in
cancer, and the more similar (conserved) amino acid substitu-
tions at the same positions, G313A, R510K and R510Q.Results and discussion
Biochemical properties of h.DPP III mutants
We puried and biochemically characterized two recombinant
protein mutants of h.DPP III, G313W and R510W, that were
found in lung adenocarcinoma, and colorectal adenocarcinoma
samples respectively (http://www.cbioportal.org/; accessed
September 2014), in order to test their enzymatic activities in
comparison to wt h.DPPIII. Both residues are located in
conserved regions of the family M49 (DPP III family), with R510
being the part of EECRAE motif of the active site, and G313
being the part of the rst conserved region (amino acids 313 to
332).9 Both Gly313 and Arg510 are completely conserved among
M49 family members (Fig. S1†). Since these amino acid
substitutions, G313W and R510W, almost abolished h.DPP III
activity towards its preferred Arg2-2NA substrate (Table 1), we
puried and biochemically characterized three more mutantsTable 1 Speciﬁc activity towards Arg2-2NA, and substrate speciﬁcity
of the h.DPP III, wt and the mutantsa
Protein
h.DPP III
Specic activity/
nmol min1 mg1 RA Ala-Arg-2NA/% RA Phe-Arg-2NA/%
WT 47 900 26 27
G313W 2 40 40
G313A 76 6 20
R510W 31 18 23
R510K 21 515 25 19
R510Q 3284 5 5
a RA Relative activity towards substrates (normalized to that for Arg2-
2NA).
This journal is © The Royal Society of Chemistry 2017with more conservative amino acid substitutions at the same
positions, G313A, R510K, and R510Q.
Measurements of specic activity of the wt h.DPP III and the
mutants towards Arg2-2NA showed that tryptophan mutants,
G313W and R510W, have approximately 24 000, and 1600 fold
lower specic activity than the wt h.DPP III, respectively.
Substitution of alanine at amino acid residue 313 increased the
activity of the protein compared to the G313Wmutant, however,
it was still considerably lower than the wt h.DPP III, showing
that glycine at position 313 is essential for the h.DPP III activity.
On the other hand, substitution by lysine instead of tryptophan
at position 510 returned the specic activity of the mutant to
approximately half of the activity of the wt h.DPP III, while
substitution by glutamine raised enzyme activity comparing to
the R510W mutant, but the mutant R510Q still had approxi-
mately 14 fold lower specic activity than the wt h.DPP III (Table
1). That result showed that for the eﬃcient enzymatic
activity h.DPP III requires a positively charged amino acid at
position 510. The pH optimum for Arg2-2NA hydrolysis was
around 8.6 for R510 mutants, while G313W, and G313A had the
optimum at pH 8.0, and 7.4, respectively. The studied substi-
tutions slightly change the relative preferences for diﬀerent
dipeptidyl 2-naphthylamides (Arg2-2NA, Ala-Arg-2NA and Phe-
Arg-2NA) compared to the wt, however, Arg2-2NA was still the
preferred substrate for all mutants (Table 1).
The catalytic properties of the wt h.DPP III and all mutated
forms were determined for the hydrolysis of characteristic
synthetic substrate Arg2-2NA from two or three independent
measurements at pH 8.6 (Table 2), except for the G313A whose
catalytic properties were determined from one measurement at
pH 7.4. We did not determine the G313W kinetic parameters
due to extremely low enzymatic activity of that mutant. All
tested proteins showed similar KM as the wt h.DPP III, except
G313A that had more than 20 times higher KM, while kcat
diﬀered by 2–3 orders of magnitude for mutants G313A and
R510W, respectively. The kcat value of R510Q was 26 times lower
than the wt, and R510K had similar kcat as the wt.
We have revealed or conrmed the importance of several
conserved amino acid residues situated outside of the two
active-site motifs H450ELLGH455 and E507ECRAE512, in human
DPP III (Tyr318, Trp300, His568, Asp496), so far.19–22 Among
previously characterized h.DPP III mutants, H568N showed theTable 2 Kinetic characterization of h.DPPIII, wt and mutantsa
Protein h.DPP
III KM/mM kcat/s
1 kcat/KM  106 M1 s1
WT 5.45  0.53 35.400  6.364 6.475  0.538
G313W — — —
G313A 114.57 0.224 0.002
R510W 4.48  1.49 0.012  0.003 0.003  0.000
R510K 4.06  0.87 27.533  9.905 7.066  3.269
R510Q 2.10  1.32 1.350  0.365 0.864  0.533
a The values are the average st. dev. of 2 (WT and R510W) or 3 (R510K
and R510Q) independent measurements at pH 8.6, except G313A for
which we conducted 1 measurement at pH 7.4.
RSC Adv., 2017, 7, 36326–36334 | 36327
Table 3 The Zn2+ coordination and the range of Rgyr traced during
simulations of diﬀerent human DPP III variants. Data obtained during
two 100 ns long MD simulations (see Table S1) are given. Details of all
simulations performed within this work are given in Table S1. Letters
‘m’ and ‘b’ denotemonodentate and bidentate coordination of Zn2+ by
Glu451 and Glu508 carboxyl groups, respectively
h.DPP III variant
Zn2+ coordination Rgyr
H450 H455 E451 E508 Range (A˚)
WT + + m m 26.9–28.4
G313W + + m m/b 26.2–28.6
G313A + + m m/b 26.4–28.5
R510K + a m m/b 26.3–28.2
R510W + + m m 26.2–28.3
R510Q + a m m 26.4–28.4
WT-closed + + m m/b 25.0–25.5
WT-RRNA + + m b 24.9–25.5
G313W-RRNA + + m/b b 24.8–25.6
G313A-RRNA + + m/b b 24.9–25.5
R510W-RRNA + + m b 24.9–25.7
R510Q-RRNA + + m/b m/b 24.8–25.5
R510K-RRNA + + m m/b 24.8–25.7
a In the case of two simulation of variants, R510K and R510Q, His455
reoriented and during about 4.5% of the total simulation time (200
ns) have not coordinated the zinc ion.
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View Article Onlinelowest kcat value for the hydrolysis of Arg2-2NA, three orders of
magnitude lower than the wt h.DPP III,21 without signicant
change in KM value. According to steady-state kinetic parame-
ters, this protein variant is similar to R510W characterized in
our present study.Molecular simulations
We simulated 6 diﬀerent variants of h.DPP III, wild type and its
mutants, G313A, G313W, R510K, R510Q and R510W. AllFig. 1 (left) Structure of wild type DPP III (light grey) in complex with pr
mutated residues (yellow) and the active site Zn2+ (grey sphere), (right) p
obtained after 100 ns of MD simulations. The distances (in A˚) between c
36328 | RSC Adv., 2017, 7, 36326–36334variants were simulated without substrate and in complex with
the substrate Arg2-2NA (RRNA), see Table 3. For each variant we
performed four MD simulations (100 ns long), two for the
ligand free enzyme variant and two for its complex with Arg2-
2NA, see Table S1.† Structure of the wt h.DPP III–RRNA complex
is shown in Fig. 1 and positions of the amino acid residues
mutated in this study are indicated. Inuence of the mutations
to the protein structure and exibility was studied using the
structure of the ligand free enzyme in its open form, while the
inuence of the point mutations on the ligand binding was
studied using the closed form of the enzyme complexed with
the preferred synthetic substrate Arg2-2NA. Our earlier
studies13,14,16 showed that such a closed enzyme form is the
active one, i.e. it ensures environment suitable for the peptide
hydrolysis. Orientation of Arg2-2NA in the active site of the
closed form closely resembles the position of Leu-enkephalin in
the human DPP III binding site, for which the reaction mech-
anism was determined using QM/MM approach.16
For the G313W variant, two diﬀerent orientation of the
indole ring were considered. In one, the Trp side chain at
position 313 points towards the active site and in the other it
points toward the lower domain interior. However, since the
orientation toward the lower domain interior turned out to be
unfavourable, in this work we consider only results obtained
with Trp313 pointing towards the interdomain cle active site.
According to the results of MD simulations, the point mutations
at positions 313 and 510, G313A, G313W, R510K, R510Q, and
R510W do not inuence the metal ion coordination (Table 3).
The simulations showed that, like in the wt protein,25 the Zn2+
ion is mostly hexacoordinated in the simulated mutants, as
well. In the ligand free variants the metal dication was coordi-
nated by two histidines, H450 and H455, two glutamates, E451
and E508, and one or two water molecules, depending on the
position of E451 and E508 carboxyl groups, during theeferred synthetic substrate Arg2-2NA (cyan), with marked positions of
art of the beta-sheet core of the enzyme and the coordination of Zn2+
oordinating atoms and Zn2+ are presented.
This journal is © The Royal Society of Chemistry 2017
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View Article Onlinesimulations. The water molecules coordinating Zn2+ oen
exchanged with bulk water during the simulations and they are
not shown in Fig. 1. In the case of two simulation (variants
R510K and R510Q) His455 reoriented, and during about 4.5% of
the total simulation time have not coordinated the zinc ion.
However, during the simulations of the other two replicas of the
same variants the zinc coordination has been preserved during
entire simulation time. Apparently, the zinc ion coordination is
mostly preserved in all simulations and rarely occurring re-
orientation of H455 can be attributed to the stochastic nature of
the simulations.MD-simulations of the ligand free h.DPP III variants
Although the mutations at positions 313 and 510 do not
signicantly inuence the overall protein fold and the Zn2+ ion
coordination, they induce local structural changes which distort
the active site conformation, and in this way hinder substrate
positioning in the orientation that is the most suitable for the
enzymatic reaction. Gly313 is located in the b6 sheet of
the h.DPP III lower domain. At the end of the sheet there is
a Glu316 residue, which upon protein closure approaches the
substrate and interacts electrostatically with the N-terminal
amino group of its rst amino acid residue (Fig. S2†). The
residue conservation within M49 family and large decrease of
the G313W mutant enzyme activity, suggest that Gly residue at
position 313 is essential for proper positioning of the substrate
upon closing of the domains.
MD simulations revealed that, although Gly313 does not
interact with the substrate, it dictates the position of Glu316.
Indeed, Trp at position 313 distorts the b6 sheet conforma-
tion, changes the Glu316 position and prevents proper
substrate positioning in the active site (Fig. 2 and S2†). The
kinetic parameters of G313W mutant could not be determined
due to its low activity and KM of the more conservative mutant
G313A was signicantly increased compared to the wt (Table 2).Fig. 2 Position of residues 313 (Gly and Trp, respectively) and Glu316
in b-sheets b6–b7 in wt protein (grey) and mutant variant (yellow), in
representative structures of 100 ns simulations. The distance (in A˚)
between Trp313 and Glu316 of mutant structure is labeled. Zn2+ is
represented as a grey sphere and the residues of active site are shown
as sticks.
This journal is © The Royal Society of Chemistry 2017This supports the nding that the mutation in G313 in general
does not prevent the substrate binding, but disturbs its posi-
tioning in the active site in the catalytically productive
orientation.
In order to get an insight into the overall protein exibility,
and to nd out how the point mutations inuence this exi-
bility, we computed the average Root Mean Square Fluctuations
(RMSF) for the wild type protein and its mutants (Fig. 3). The
results show that the lower (satellite) domain, especially its N
and C terminal segments (residues 4 to 300 and 680 to 726,
respectively) are the most exible parts of the enzyme, followed
by the substrate binding b-sheet region, consisting of two b-
strands, b9 and b10. Analysis of the RMSF clearly indicated that
mutations, either at position 313 or in position 510, increase
protein exibility, especially of the lower domain b-core (b-
sheets b2–b3 and b9–b10). The R510K exibility closely resem-
bles that of the wild type protein.
Apparently, increased exibility of the lower domain b-core,
especially of b-sheets b2–b3 and b9–b10, is negatively correlated
with the enzyme activity. The mutants with the highest uctu-
ations determined during MD simulations were also showing
the lowest activity. On the other hand, both the activity and
exibility of R510K are very similar to those of the wild type
protein. Further on, the RMSF prole revealed that substitution
of Arg510 by Trp signicantly increases uctuations of the
H450ELLGH455 motif and its surrounding (Fig. 3 and S3†).
Consequently, the interactions between the amino acid
residues from this region with the rest of the protein are weakerFig. 3 Root Mean Square Fluctuations (RMSF) proﬁles of the human
DPP III variants obtained by averaging over two 100 ns long simula-
tions (see Table S1†).
RSC Adv., 2017, 7, 36326–36334 | 36329
Fig. 4 Position of highly conserved residue R510 (pink) in the structure
of h.DPP3 (PDB 3FVY) interacting with Gly454 (yellow, distance in A˚)
from the conserved H450ELLGH455 motif (shown as sticks) responsible
for coordinating Zn2+ (grey sphere).
RSC Advances Paper
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View Article Onlinein mutants than in the wt h.DPP III. In the wt protein, Arg510
interacts electrostatically with carbonyl groups of Gly454,
Leu453 and His455 (Fig. 4). The Arg510 to Trp and Gln muta-
tions resulted with decrease of these interactions and as
a consequence exibility of this motif increased in accord with
the RMSF results. The highest uctuation of the H450ELLGH455
motif has been found in the R510Wmutant, followed by R510Q,
while the uctuations in the R510K mutant and the wild type
protein are similar (Fig. S3†). It seems that destabilization of the
H450ELLGH455 motif does not disturb the Zn2+ coordination in
the R510W and R510Q mutants but it signicantly inuences
the enzymatic activity. This is not surprising if we know that
Glu451 directly participates in the peptide bond hydrolysis,
acting as a general base during the deprotonation of water
molecule that attacks the scissile amide bond.16 The increased
uctuations of this motif in the Arg510 mutants has been
observed in both open and closed protein forms. Apparently,
the H450ELLGH455 instability can be accounted for the
decreased peptidase activity of h.DPP III mutants.Table 4 Population of the most relevant hydrogen bonds for the
enzymatic reaction during two, 100 ns long MD simulations of
the h.DPP III variants. The hydrogen bonds were calculated with
CPPTRAJ using default parameters. However, only H-bonds with
distances #2.5 A˚ are listed in the table
Residues
% H-bond
Variant
wt G313W G313A R510W R510Q R510K
Y318–E327 66 87 52 31 78 34
H450–H455 22 22 19 17 19 14
E451–N406 59 41 11 49 52 55
H455–S457 2 3 3 2 3 16
H455–E507 84 89 86 63 77 73
E508–S504 8 11 6 5 4 8
E512–H568 68 74 32 73 70 61
X510–G454 78 80 74 35 12 13
X510–S457 62 50 72 6 1 4
X510–Q626 73 71 79 2 78 7
36330 | RSC Adv., 2017, 7, 36326–36334Additionally, the hydrogen bond between residue 510 and
Ser457, present in the wild type enzyme, is signicantly less
stable in Arg510 mutants, while the Arg510–Gln626 hydrogen
bond is preserved in the R510Q mutant, but not in R510W and
R510K mutants (Table 4). Further on, the hydrogen bond
between fully conserved Tyr318 and Glu327 is preserved in the
R510Q but not in R510K and R510W mutants.MD-simulations of the h.DPP III–Arg2-2NA complexes
In the studied complexes two arginine residues of the substrate
(Arg2-2NA) form a b-strand that in the antiparallel fashion binds
to the ve-stranded b-core of DPP III (as shown in Fig. 1). Such
binding closely resembles the tynorphin binding mode in the
experimentally determined structure of the inactive DPP III
mutant–tynorphin complex.26 Binding of the substrate Arg2-2NA
into the active site of human DPP III stabilized the protein
structure, especially the lower domain b-core (Fig. 3 and 5) and
slightly changed the exibility prole pattern. Apparently,
binding of the synthetic substrate Arg2-2NA to the b9 and b10
sheets decreases their mobility in the wt protein. However,
despite the striking similarity of the substrate orientation in the
simulated variants, the protein structure stabilization induced
by the substrate binding is not the same in all variants (Fig. S4
and S5†), and the complex with the R510W mutant isFig. 5 Root Mean Square Fluctuations (RMSF) calculated for the 100
ns of MD simulations of the complexes between diﬀerent human DPP
III variants and Arg2-2NA obtained by averaging over two 100 ns long
simulations.
This journal is © The Royal Society of Chemistry 2017
Table 5 Populations of the selected intra- and intermolecular hydrogen bonds averaged over two 100 ns long MD simulations of h.DPP III
variants–Arg2-2NA complexes. The hydrogen bonds were calculated with CPPTRAJ using default parameters. H-bonds with distances below
2.51 are listed in the table
H-bonds WT-RRNA R510W-RRNA R510Q-RRNA G313W-RRNA G313A-RRNA
Y318–D496 <1 <1 40 3 97
Y318–E508 76 44 1 85 <1
Y318–H568 <1 <1 21 <1 1
X510–G454 57 34 <1 74 41
X510–Q626 68 <1 71 76 63
E512–H450 88 73 71 80 90
E316–RRNA 100 99 100 100 56
E329–RRNA 21/63 87 100 100 95
G385–RRNA 49 <1 5 <1 <1
G389–RRNA 54 77 74 55 <1
N391–RRNA 51 100 88 100 77
N394–RRNA 89 64 90 88 83
D396–RRNA 50 23 45 62 84
D496–RRNA 41 85 95 100 96
H568–RRNA 47 7 8 <1 <1
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View Article Onlinesignicantly more exible than the other simulated complexes
(Fig. S3†).
The hydrogen bond analysis revealed that, similarly to the
ligand free protein, interaction between residues at position 510
and Gln626 is completely abolished in the R510W–Arg2-2NA
mutant complex, while the hydrogen bond between Arg510 and
Gly454 has not been detected during the simulation of the
R510Q complex (Table 5). Oppositely, the Tyr318 stabilization
by Asp496 and His568 is the most stable in the complex with the
G313A and the R510Q mutant, respectively (Fig. S7†) as
conrmed by the hydrogen bond analysis (Table 5). We have
showed that the 100% conserved Tyr318 is important for
substrate stabilization in the active site.16 Its reorientation into
direction of either Asp496 or His568might be one of the reasons
for the enzymatic inactivation of the R510Q mutant, also.
Analysis of the substrate–protein hydrogen bonds revealed thatFig. 6 The representative structure of the h.DPP III–Arg2-2NA
complex. The residues interacting with the substrate are presented as
grey and the substrate as cyan sticks. The distances are given in A˚.
This journal is © The Royal Society of Chemistry 2017in general there are no signicant diﬀerences among the
complexes (Fig. 6, S4 and S5†). However, the stability of the
hydrogen bond between the substrate and highly conserved
residue G385 as well as the catalytic histidine H568 is the most
stable in the complex with wt enzyme (Table 5 and Fig. 6 and
S6†). It has been shown that His568 plays a signicant role in
the transition state stabilisation and the enzymatic reaction. By
forming a stable hydrogen bond with the substrate carbonyl
oxygen, His568 is dragging the negative charge away from the
peptide C atom and in this way facilitates nucleophile attack of
the activated water.16 So the lack of this hydrogen bond in the
complexes with mutated protein may explain the enzymatic
inactivity of these variants.Conclusions
We expressed and biochemically characterized two mutant h.DPP
III proteins, G313W and R510W, with mutations in the highly
conserved regions of DPP III, to analyse their biochemical and
physicochemical properties in comparison to the wild type h.DPP
III. Aforementioned mutants exhibited dramatically lower activity
towards the synthetic DPP III substrate, Arg2-2NA, which promp-
ted us to investigate the origins of that activity loss by combining
experimental and computational approach. We also analysed 3
additional mutants with more conservative amino acid substitu-
tion at the same positions, G313A, R510K and R510Q. The results
of these investigations gave new insight into biochemical and
structural importance of conserved residues Gly313 and Arg510
for the enzyme activity. Experimental approach indicated that
Gly313 to Ala mutation signicantly inuences the binding of the
Arg2-2NA substrate in contrast to themutations of Arg510 that did
not result in the signicant change of KM. In agreement with
biochemical results, MD simulations revealed that Gly313 is
essential for the proper positioning of the substrate, although
there is no direct contact between them. However Gly313 dictates
position of Glu316, conserved residue that interactsRSC Adv., 2017, 7, 36326–36334 | 36331
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View Article Onlineelectrostatically with the N-terminal amino group of the substrate.
The eﬃciency of Arg2-2NA hydrolysis (kcat/KM) was signicantly
decreased in all mutants except R510K. One possible reason for
the enzymatic inactivity of the mutants is increased exibility of
their active site in comparison with the wild type enzyme, and the
other is lack of the hydrogen bond between the substrate and
catalytic His568, which is known to be important for the transi-
tion state stabilization.16
Apparently, the disrupted hydrogen bond between Arg2-2NA
and catalytic His568 in combination with the increased active
site uctuations, especially of the H450ELLGH455 motif provide
possible explanation for inactivity of the G313W and R510W
mutants.
This is the rst report on negative correlation of DPP III
activity with increased exibility of the lower domain b-core.
Experimental
Protein expression and purication
Mutants of h.DPP III, G313W, G313A, R510W, R510K and
R510Q were prepared by site-specic mutagenesis of wt h.DPP
III His-tagged expression construct cloned in pET21b vector
with QuikChange II XL Site-Directed Mutagenesis kit (Agilent
technologies, USA). Proteins were expressed in E. coli strain
BL21-CodonPlus(DE3)-RIL, and puried by Ni-NTA aﬃnity
chromatography, as described by Sˇpoljaric´ et al. (2011).23
Protein concentrations were determined using the protein-
dye binding assay, with bovine serum albumin as a standard.24
Enzyme activity assay and determination of kinetic
parameters
The enzymatic activities of wt and mutant h.DPP IIIs were
determined by a standard assay at 37 C with Arg2-2NA as
a substrate, using the colorimetric method as previously
described.25 Kinetic parameters for hydrolysis of Arg2-2NA were
determined at 25 C and at pH 8.6 for mutants R510W, R510K
and R510Q, and at pH 7.4 for G313A, in the presence of 50 mM
CoCl2 by initial rate measurements, as previously described.25
The kinetic parameters were calculated using Hanes–Woolf
plot, with Arg2-2NA concentrations from 2.5 to 40 mM for all
mutants except G313A for which concentrations range from 20
to 240 mMwas used. Kinetic parameters for mutant G313Wwere
not determined due to low enzyme activity.
Molecular simulations
Model setup. In this work we used two h.DPP III conforma-
tions of diﬀerent compactness, the compact, catalytic one (PDB
code: 3T6B26) and the less compact, so called ‘open’ confor-
mation (PDB code: 3FVY). The chloride and magnesium ions
present in these structures, as well as the crystalized water
molecules, were removed, and the proper protonation of active
site residues was set up using the tleap module (part of the
AMBER14 suite of programs).27 All Arg and Lys residues were
positively charged and all Glu and Asp residues were negatively
charged, as expected under the physiological conditions.
Protonation states of histidine residues were determined36332 | RSC Adv., 2017, 7, 36326–36334according to their ability to form hydrogen bonds with neigh-
bouring amino acid residues. Mutated enzymes were prepared
using model leap. For the purpose of selecting an amino acid
rotamer at the mutated position we used the program Pymol
(backbone dependent approach). However we have not selected
the most populated rotamer, but the one that ts into the
enzyme structure the best. For the G313W mutant two diﬀerent
Trp313 rotamers were considered, one pointing towards the
inter-domain cle and the other towards the lower domain. The
rst one (chi angles 182.1, 180.0) appeared to be more
favourable during the preliminary simulations so it was selected
for the further study. For the R510W mutant the most favour-
able rotamer, with the chi angles 164.9 and 257.4, was
considered. DPP III–RRNA complexes were constructed using
utilities of the program Pymol (The PyMOL Molecular Graphics
System, Version 1.7 Schro¨dinger, LLC.). We used the crystal
structure of the DPP III mutant–tynorphin complex (PDB code:
3T6B) as a template, aligned RRNA to tynorphin and mutated
Ala451 back to Glu in order to obtain the wild type enzyme. The
complexes with the other variants were obtained by mutation of
corresponding amino acid residues. The obtained complexes
were energy-minimized and equilibrated during short MD
simulations.
The enzyme variants, either ligand free or its complexes with
the synthetic substrate Arg2-2NA, were neutralized by adding
Na+ ions and solvated in an octahedron box lled with TIP3P28
water molecules ensuring an at least 11 A˚ thick water molecules
buﬀer around the protein. The systems were parametrized by
the AMBERTools14 modules antechamber and tleap, using
GAFF29 and ﬀ14SB30 force elds to parameterize the substrate
and the protein, respectively. For the zinc cation, Zn2+, param-
eters were derived from our previous work12 and modied
according to the PDB survey.31,32
Molecular dynamics simulations. The resulting system,
consisting of 95 000 (ligand free) and 64 000 (complexes)
atoms (27 500 and 17 500 molecules of water, respectively),
were simulated using periodic boundary conditions. The elec-
trostatic interactions were calculated using the particle-mesh
Ewald method.33 The PMEMD module running at GPU was
used to conduct the molecular dynamics (MD) simulation.
Before MD simulations, three rounds of geometry optimization,
with diﬀerent degree of the protein restraints, were performed
by the module sander. In the rst cycle 1500 optimization steps
were performed, where the rst 450 steps were of the steepest
descent method, and the rest was the conjugate gradient. Both,
the protein atoms and the metal ion, were constrained using
a harmonic potential of 32 kcal (mol A˚2)1, in order to equili-
brate water molecules. In the second cycle 2500 steps of opti-
mization was done. The metal ion and the protein backbone
were constrained with 12 kcal (mol A˚2)1. Finally, in the third
cycle the same number of optimization steps was used as in the
rst cycle, and the protein backbone and the metal ion were
constrained with 1 kcal (mol A˚2)1 and 12 kcal (mol A˚2)1,
respectively. The minimized system was heated from 0 to 300 K
during 30 ps of MD simulation using a canonical ensemble
(NVT), followed by equilibration stage of 30 and 100 ps (for the
ligand free enzyme and complexes), during which the waterThis journal is © The Royal Society of Chemistry 2017
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View Article Onlinedensity was adjusted. The equilibrated system was then sub-
jected to 100 ns of the productive MD simulations, 50 ns of
conventional MD (cMD) followed by 50 ns of the dual boost
accelerated MD (aMD) simulations. One boost was applied to
torsional terms and the other to total potential. The latter
facilitates diﬀusion of the explicit solvent molecules around the
biomolecule and thus reduces hindrance that water induce on
the large amplitude displacements of a solute. In this way more
eﬃcient conformational sampling is enabled.
Type and duration of the performed simulations is given in
Table S1.†34 The constant temperature (300 K) and pressure (1
atm) were ensured using Langevin dynamics with a collision
frequency of 1 ps1, and Berendsen barostat, respectively.35,36
The time step during the periods of heating and cooling was 1
fs, and for the rest of the simulation 2 fs (to restrain the motion
of hydrogens the SHAKE algorithm was used).
Data analysis. In order to analyse and to characterize inu-
ence of the mutations on the protein structure and exibility,
several geometric parameters were analysed such as the Zn2+ ion
coordination, RMSD, RMSF and radius of gyration, Rgyr (RMSD
and Rgyr were calculated for the backbone atoms and RMSF for
Ca atoms only). These analysis, in which the backbone atoms
were used for calculations, as well as the analysis of the hydrogen
bonds population, were performed using the program cpptraj,
a part of the AMBER14 suite. For the purpose of selecting the
representative structures for visualization we performed several
types of clustering: based on the entire protein structure, based
on the orientation of the mutated residue and based on the
substrate binding mode. Figures were prepared using a structure
from the most populated cluster obtained by one of the above
listed methods. In the case of the wt, protein clustering based on
the entire protein structure was used and in the case of mutants
clustering was based on the orientation of the mutated amino
acid residues. For the purpose of visualization of the ligand
bound into the enzyme active site, clustering based on substrate
RMSD (calculated for the all substrate atoms) was used to select
the most representative binding mode.Conﬂict of interest
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